How Peptides Signal: A Plain-English Primer

A peptide doesn't act on the body directly. It acts on a receptor, and the cell carrying that receptor does the rest. Strip away the specifics of any individual compound and the mechanism is the same three-step relay every time: the peptide binds a specific receptor on or in a target cell, that binding event triggers an intracellular signaling cascade, and the cascade converges on transcription factors or effector proteins that change what the cell actually does, secrete a hormone, contract, migrate, divide, or survive.

A detailed review of the oxytocin receptor system lays out this exact relay for one well-studied peptide hormone: the oxytocin receptor is a seven-transmembrane G protein-coupled receptor that, once bound, activates a set of intracellular signaling cascades, including the MAPK, PKC, PLC, and CaMK pathways, that converge on transcription factors like CREB and MEF-2 to produce the cellular response (Jurek B & Neumann ID, 2018, Physiological Reviews). Swap out the specific receptor and the specific downstream kinases, and that's the shape of how every peptide covered on this site works: bind, cascade, respond. What changes from compound to compound is which receptor gets bound, where that receptor sits in the body, and which cascade it triggers.

CJC-1295: binding the GHRH receptor to amplify a GH pulse

CJC-1295's own mechanism, as described on its compound page, is a GHRH analog that binds pituitary GHRH receptors to amplify pulsatile GH secretion, with the DAC variant extending half-life via albumin binding and the no-DAC variant mimicking natural GH pulses. That's the relay in miniature: receptor binding at the pituitary drives a hormonal cascade, GH release, that then acts through its own receptor elsewhere in the body to produce the body-composition and recovery effects people track when they use it. CJC-1295's page covers the full dosing, half-life, and stacking detail.

Semax: an ACTH fragment signaling toward growth factors

Semax is a synthetic analog of ACTH 4-10. Its mechanism, per its own compound page, increases BDNF, NGF, and VEGF expression and enhances dopaminergic and serotonergic neurotransmission, producing neuroprotective and cognitive-enhancing effects. The receptor targets here sit in the brain rather than the pituitary, which is why a signal built from the same ACTH-related family shows up as focus, memory, and neuroprotection instead of a GH pulse. Semax's compound page has the full mechanism and protocol detail.

BPC-157: several signaling routes converging on one outcome

Not every peptide runs through a single receptor-cascade pair. BPC-157's own compound page describes it as promoting angiogenesis via VEGF, upregulating GH receptors in tendon fibroblasts, modulating the nitric oxide system, and activating the FAK-paxillin pathway for cell migration, four separate signaling routes feeding into the same outcome: tissue repair. That's part of why BPC-157 shows up across gut healing, tendon repair, and general recovery protocols on this site rather than one narrow use case. The signal isn't a single switch, it's several switches wired to the same result. BPC-157's compound page breaks down each pathway individually.